^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    HRS-5041

    i
    Other names: HRS-5041
    Associations

    News

    Trials
    Company:
    Jiangsu Hengrui Pharma
    Drug class:
    Androgen receptor degrader
    Related drugs:
    Associations

    News

    Trials
    7ms
    Study of HRS-5041 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC) (clinicaltrials.gov)
    P1, N=100, Recruiting, Jiangsu HengRui Medicine Co., Ltd. | Not yet recruiting --> Recruiting
    Enrollment open • Metastases
    |
    HRS-5041
    10ms
    Study of HRS-5041 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC) (clinicaltrials.gov)
    P1, N=100, Not yet recruiting, Jiangsu HengRui Medicine Co., Ltd.
    New P1 trial • Metastases
    |
    HRS-5041